With the strong support of the local government, the orthopedic surgical robot developed by this enterprise was only included in the Beijing charging directory at the end of 2018. Currently, the supply of tubes has only been included in the charging directory in a few provinces across the country. Furthermore, even if they are included in the charging directory, there is a lack of unified pricing standards in various regions, and the differences are significant. The person in charge of a biotechnology company in Hangzhou introduced that the price department of a certain province where the tubes were supplied to the company set a charge of only 40 yuan for a domestic alternative testing product, which was not even enough to cover the cost. In other provinces, the charge was 200 to 300 yuan, while the price of similar imported products from the United States was 800 yuan. The company had no choice but to give up the market in that province.
